The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Tissue Engineered Skin Substitutes Market Research Report 2024

Global Tissue Engineered Skin Substitutes Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1564053

No of Pages : 77

Synopsis

The global Tissue Engineered Skin Substitutes market was valued at US$ 1571.8 million in 2023 and is anticipated to reach US$ 3109.6 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.

North American market for Tissue Engineered Skin Substitutes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tissue Engineered Skin Substitutes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Tissue Engineered Skin Substitutes include Amarantus BioScience Holdings, Acelity L.P., Inc., BSN medical, Integra LifeSciences Corporation, Medtronic (Covidien), Molnlycke Health Care, Smith & Nephew plc and Organogenesis, Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Tissue Engineered Skin Substitutes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue Engineered Skin Substitutes.

Report Scope

The Tissue Engineered Skin Substitutes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tissue Engineered Skin Substitutes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tissue Engineered Skin Substitutes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Amarantus BioScience Holdings
  • Acelity L.P., Inc.
  • BSN medical
  • Integra LifeSciences Corporation
  • Medtronic (Covidien)
  • Molnlycke Health Care
  • Smith & Nephew plc
  • Organogenesis, Inc

Segment by Type

  • Acellular
  • Cellular Allogeneic
  • Cellular Autologous
  • Others

Segment by Application

  • Burn Injury
  • Diabetic
  • Vascular Ulcer
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tissue Engineered Skin Substitutes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tissue Engineered Skin Substitutes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Tissue Engineered Skin Substitutes Market Overview
1.1 Product Overview and Scope of Tissue Engineered Skin Substitutes
1.2 Tissue Engineered Skin Substitutes Segment by Type
1.2.1 Global Tissue Engineered Skin Substitutes Market Value Comparison by Type (2024-2030)
1.2.2 Acellular
1.2.3 Cellular Allogeneic
1.2.4 Cellular Autologous
1.2.5 Others
1.3 Tissue Engineered Skin Substitutes Segment by Application
1.3.1 Global Tissue Engineered Skin Substitutes Market Value by Application: (2024-2030)
1.3.2 Burn Injury
1.3.3 Diabetic
1.3.4 Vascular Ulcer
1.3.5 Others
1.4 Global Tissue Engineered Skin Substitutes Market Size Estimates and Forecasts
1.4.1 Global Tissue Engineered Skin Substitutes Revenue 2019-2030
1.4.2 Global Tissue Engineered Skin Substitutes Sales 2019-2030
1.4.3 Global Tissue Engineered Skin Substitutes Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tissue Engineered Skin Substitutes Market Competition by Manufacturers
2.1 Global Tissue Engineered Skin Substitutes Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tissue Engineered Skin Substitutes Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tissue Engineered Skin Substitutes Average Price by Manufacturers (2019-2024)
2.4 Global Tissue Engineered Skin Substitutes Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tissue Engineered Skin Substitutes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tissue Engineered Skin Substitutes, Product Type & Application
2.7 Tissue Engineered Skin Substitutes Market Competitive Situation and Trends
2.7.1 Tissue Engineered Skin Substitutes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tissue Engineered Skin Substitutes Players Market Share by Revenue
2.7.3 Global Tissue Engineered Skin Substitutes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tissue Engineered Skin Substitutes Retrospective Market Scenario by Region
3.1 Global Tissue Engineered Skin Substitutes Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tissue Engineered Skin Substitutes Global Tissue Engineered Skin Substitutes Sales by Region: 2019-2030
3.2.1 Global Tissue Engineered Skin Substitutes Sales by Region: 2019-2024
3.2.2 Global Tissue Engineered Skin Substitutes Sales by Region: 2025-2030
3.3 Global Tissue Engineered Skin Substitutes Global Tissue Engineered Skin Substitutes Revenue by Region: 2019-2030
3.3.1 Global Tissue Engineered Skin Substitutes Revenue by Region: 2019-2024
3.3.2 Global Tissue Engineered Skin Substitutes Revenue by Region: 2025-2030
3.4 North America Tissue Engineered Skin Substitutes Market Facts & Figures by Country
3.4.1 North America Tissue Engineered Skin Substitutes Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tissue Engineered Skin Substitutes Sales by Country (2019-2030)
3.4.3 North America Tissue Engineered Skin Substitutes Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tissue Engineered Skin Substitutes Market Facts & Figures by Country
3.5.1 Europe Tissue Engineered Skin Substitutes Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tissue Engineered Skin Substitutes Sales by Country (2019-2030)
3.5.3 Europe Tissue Engineered Skin Substitutes Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tissue Engineered Skin Substitutes Market Facts & Figures by Country
3.6.1 Asia Pacific Tissue Engineered Skin Substitutes Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tissue Engineered Skin Substitutes Sales by Country (2019-2030)
3.6.3 Asia Pacific Tissue Engineered Skin Substitutes Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tissue Engineered Skin Substitutes Market Facts & Figures by Country
3.7.1 Latin America Tissue Engineered Skin Substitutes Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tissue Engineered Skin Substitutes Sales by Country (2019-2030)
3.7.3 Latin America Tissue Engineered Skin Substitutes Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tissue Engineered Skin Substitutes Market Facts & Figures by Country
3.8.1 Middle East and Africa Tissue Engineered Skin Substitutes Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tissue Engineered Skin Substitutes Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tissue Engineered Skin Substitutes Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Tissue Engineered Skin Substitutes Sales by Type (2019-2030)
4.1.1 Global Tissue Engineered Skin Substitutes Sales by Type (2019-2024)
4.1.2 Global Tissue Engineered Skin Substitutes Sales by Type (2025-2030)
4.1.3 Global Tissue Engineered Skin Substitutes Sales Market Share by Type (2019-2030)
4.2 Global Tissue Engineered Skin Substitutes Revenue by Type (2019-2030)
4.2.1 Global Tissue Engineered Skin Substitutes Revenue by Type (2019-2024)
4.2.2 Global Tissue Engineered Skin Substitutes Revenue by Type (2025-2030)
4.2.3 Global Tissue Engineered Skin Substitutes Revenue Market Share by Type (2019-2030)
4.3 Global Tissue Engineered Skin Substitutes Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tissue Engineered Skin Substitutes Sales by Application (2019-2030)
5.1.1 Global Tissue Engineered Skin Substitutes Sales by Application (2019-2024)
5.1.2 Global Tissue Engineered Skin Substitutes Sales by Application (2025-2030)
5.1.3 Global Tissue Engineered Skin Substitutes Sales Market Share by Application (2019-2030)
5.2 Global Tissue Engineered Skin Substitutes Revenue by Application (2019-2030)
5.2.1 Global Tissue Engineered Skin Substitutes Revenue by Application (2019-2024)
5.2.2 Global Tissue Engineered Skin Substitutes Revenue by Application (2025-2030)
5.2.3 Global Tissue Engineered Skin Substitutes Revenue Market Share by Application (2019-2030)
5.3 Global Tissue Engineered Skin Substitutes Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amarantus BioScience Holdings
6.1.1 Amarantus BioScience Holdings Corporation Information
6.1.2 Amarantus BioScience Holdings Description and Business Overview
6.1.3 Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Product Portfolio
6.1.5 Amarantus BioScience Holdings Recent Developments/Updates
6.2 Acelity L.P., Inc.
6.2.1 Acelity L.P., Inc. Corporation Information
6.2.2 Acelity L.P., Inc. Description and Business Overview
6.2.3 Acelity L.P., Inc. Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Acelity L.P., Inc. Tissue Engineered Skin Substitutes Product Portfolio
6.2.5 Acelity L.P., Inc. Recent Developments/Updates
6.3 BSN medical
6.3.1 BSN medical Corporation Information
6.3.2 BSN medical Description and Business Overview
6.3.3 BSN medical Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BSN medical Tissue Engineered Skin Substitutes Product Portfolio
6.3.5 BSN medical Recent Developments/Updates
6.4 Integra LifeSciences Corporation
6.4.1 Integra LifeSciences Corporation Corporation Information
6.4.2 Integra LifeSciences Corporation Description and Business Overview
6.4.3 Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Product Portfolio
6.4.5 Integra LifeSciences Corporation Recent Developments/Updates
6.5 Medtronic (Covidien)
6.5.1 Medtronic (Covidien) Corporation Information
6.5.2 Medtronic (Covidien) Description and Business Overview
6.5.3 Medtronic (Covidien) Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medtronic (Covidien) Tissue Engineered Skin Substitutes Product Portfolio
6.5.5 Medtronic (Covidien) Recent Developments/Updates
6.6 Molnlycke Health Care
6.6.1 Molnlycke Health Care Corporation Information
6.6.2 Molnlycke Health Care Description and Business Overview
6.6.3 Molnlycke Health Care Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Molnlycke Health Care Tissue Engineered Skin Substitutes Product Portfolio
6.6.5 Molnlycke Health Care Recent Developments/Updates
6.7 Smith & Nephew plc
6.6.1 Smith & Nephew plc Corporation Information
6.6.2 Smith & Nephew plc Description and Business Overview
6.6.3 Smith & Nephew plc Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Smith & Nephew plc Tissue Engineered Skin Substitutes Product Portfolio
6.7.5 Smith & Nephew plc Recent Developments/Updates
6.8 Organogenesis, Inc
6.8.1 Organogenesis, Inc Corporation Information
6.8.2 Organogenesis, Inc Description and Business Overview
6.8.3 Organogenesis, Inc Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Organogenesis, Inc Tissue Engineered Skin Substitutes Product Portfolio
6.8.5 Organogenesis, Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tissue Engineered Skin Substitutes Industry Chain Analysis
7.2 Tissue Engineered Skin Substitutes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tissue Engineered Skin Substitutes Production Mode & Process
7.4 Tissue Engineered Skin Substitutes Sales and Marketing
7.4.1 Tissue Engineered Skin Substitutes Sales Channels
7.4.2 Tissue Engineered Skin Substitutes Distributors
7.5 Tissue Engineered Skin Substitutes Customers
8 Tissue Engineered Skin Substitutes Market Dynamics
8.1 Tissue Engineered Skin Substitutes Industry Trends
8.2 Tissue Engineered Skin Substitutes Market Drivers
8.3 Tissue Engineered Skin Substitutes Market Challenges
8.4 Tissue Engineered Skin Substitutes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’